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Abstract
Background: In the past several years, an increase in open reduction and internal fixation (ORIF) for intra-articular
distal radius fractures has been observed. This technique leads to a quicker recovery of function compared to
non-operative treatment. However, some patients continue to have a painful and stiff wrist postoperatively.
Arthroscopically assisted removal of intra-articular fracture haematoma and debris may improve the functional
outcomes following operative treatment of intra-articular distal radius fractures. The purpose of this randomised
controlled trial is to determine the difference in functional outcome, assessed with the Patient-Rated Wrist
Evaluation (PRWE) score, after ORIF with and without an additional wrist arthroscopy in adult patients with
displaced complete articular distal radius fractures.
Methods: In this multicentre trial, adult patients with a displaced complete articular distal radius fracture are
randomised between ORIF with an additional wrist arthroscopy to remove fracture haematoma and debris
(intervention group) and conventional fluoroscopic-assisted ORIF (control group). The primary outcome is functional
outcome assessed with the PRWE score after three months. Secondary outcomes are wrist function assessed with
the Disability of the Arm, Shoulder and Hand (DASH) score, postoperative pain, range of motion, grip strength,
complications and cost-effectiveness. Additionally, in the intervention group, the quality of reduction, associated
ligamentous injuries and cartilage damage will be assessed. A total of 50 patients will be included in this study.
Discussion: Although ORIF of intra-articular distal radius fractures leads to a quicker resume of function compared
to non-operative treatment, some patients continue to have a painful and stiff wrist postoperatively. We
hypothesise that, due to the removal of fracture haematoma and debris by an additional arthroscopy, functional
outcomes will be better compared to the non-arthroscopically treated group.
Trial registration: ClinicalTrials.gov, NCT02660515. Registered on 13 January 2016.
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Background
In the last decade, an increase in open reduction and in-
ternal fixation (ORIF) for distal radius fractures has been
observed [1–3]. In particular, intra-articular distal radius
fractures, which comprise almost 50% of all fractures [4],
are increasingly being treated operatively. This technique
leads to a quicker resume of function in the first three to
six months compared to non-operative treatment [5, 6].
However, some patients continue to have a painful and
stiff wrist postoperatively. Arthroscopically assisted re-
moval of intra-articular fracture haematoma and debris
may improve the functional outcomes following operative
treatment of intra-articular distal radius fractures [7, 8].
Moreover, during arthroscopy the quality of the reduction
[7, 9, 10] and the presence of associated ligamentous in-
juries can be assessed [11–14].
Lindau et al. already examined the frequency of associ-
ated chondral and ligament lesions with arthroscopy in
50 patients in 1997 [14]. They described 35 subchondral
haematomas in 16 cases, and an incidence of chondral
lesions of approximately 33%. These lesions may lead to
the development of osteoarthritis in the long term [15].
Additionally, 98% of the patients had a ligamentous in-
jury. However, they found no major instability in these
patients and it is uncertain if these injuries will be clinic-
ally relevant in the long term [16].
Although, no advantage of arthroscopically guided re-
duction over conventional fluoroscopic-assisted reduc-
tion in regard to functional and radiographic outcomes
was found [17], to our knowledge no studies have been
carried out to further examine the use of arthroscopy
after ORIF to remove fracture haematoma and debris
on functional outcomes. We hypothesise that, due to
the removal of fracture haematoma and debris, functional
outcomes will be better compared to the non-
arthroscopically treated group. Therefore, the purpose of
this randomised controlled trial (RCT) is to determine the
difference in functional outcome, assessed with the
Patient-Rated Wrist Evaluation (PRWE) score, after ORIF
with and without an additional wrist arthroscopy in adult
patients with displaced complete articular distal radius
fractures. Furthermore, we aim to determine the differ-
ence in functional outcomes with the Disability of the
Arm, Shoulder and Hand (DASH) score, postoperative
pain, range of motion (ROM), grip strength, complica-
tions, and cost-effectiveness. Additionally, the quality of
reduction, associated ligamentous injuries and cartilage
damage will be assessed by arthroscopy.
Methods/Design
Study objectives
The primary objective is to determine the difference in
functional outcome of ORIF with or without an additional
arthroscopy to remove the fracture haematoma and debris
in adult patients with displaced complete articular distal
radius fractures (AO/OTA type C).
The secondary objectives are to assess if additional wrist
arthroscopy leads to less postoperative pain, a better ROM
and grip strength, and fewer complications. Additionally,
cost-effectiveness for both treatments is determined.
Moreover, for patients undergoing additional wrist arth-
roscopy, the quality of reduction, associated ligamentous
injuries and cartilage damage will be assessed.
Study design
The RADAR (Operative Treatment of Intra-Articular Dis-
tal Radius Fractures With versus Without Arthroscopy)
trial is designed as a multicentre RCT, with a 1:1 alloca-
tion ratio and a superiority framework. Patients are rando-
mised between ORIF with an additional wrist arthroscopy
to remove fracture haematoma and debris (intervention
group) and conventional fluoroscopic-assisted ORIF (con-
trol group). A total of three centres in the Netherlands are
involved in recruiting patients (Additional file 1).
The design of the trial is compliant with the Standard
Protocol Items: Recommendations for Interventional
Trials [18] (Additional file 2).
Study population
The study population will consist of all adult patients
who are diagnosed with a complete articular distal radius
fracture (AO/OTA type C) where the treating surgeon
deems ORIF necessary. Independent radiologists will as-
sess and classify complete articular distal radius fracture
based on radiography according to the AO/OTA classifi-
cation of fractures. All patients undergo a computed
tomography (CT) scan of the wrist. This is standard care
in decision-making and planning for surgery [19].
Inclusion criteria
 Patients aged 18 years and older
 Displaced complete articular distal radius fracture
(AO/OTA type C) as classified on lateral, posterior-
anterior, and lateral carporadial radiographs by a
radiologist or trauma surgeon, requiring ORIF. An
additional dorsal approach is allowed only when the
dorsal capsule is not opened and thus leaving the
radiocarpal joint untreated.
 Inacceptable alignment on radiograph defined,
according to the Dutch National Guidelines [19], as:
○ radial inclination < 15°;
○ radial length (distance between lateral most
radial tip and ulnar surface) ≤ 5 mm;
○ volar angulation ≥ 20° or dorsal angulation ≥ 15°;
○ articular step-off or gap ≥ 2 mm. A gap is
defined as loss of articular congruity of the distal
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radius parallel to the articular surface and a step-
off perpendicular to the articular surface [20].
Exclusion criteria
 Dorsal plate fixation in case the radiocarpal joint
needs to be opened
 Multiple trauma patients (Injury Severity Score
(ISS) ≥ 16)
 Open distal radius fractures
 Other fractures in the ipsilateral extremity (except
for a fracture of the ulnar styloid process)
 Fracture of the contralateral wrist (distal radius,
distal ulna or one of the carpal bones)
 Patients with impaired wrist function before injury
due to arthrosis, rheumatoid arthritis, neurological
disorders or malunion of the upper limb or patients
suffering from disorders of bone metabolism other
than osteoporosis (i.e. Paget’s disease, renal
osteodystrophy, osteomalacia) or connective tissue
disease or (joint) hyperflexibility disorders such as
Marfan’s or Ehler Danlos
 Patients with insufficient comprehension of the
Dutch language to understand the study information
and informed consent process, the rehabilitation
program and other treatment information as judged
by the attending physician
Interventions
All patients will be treated by a certified (orthopaedic)
trauma surgeon with experience in ORIF of distal radius
fractures and wrist arthroscopy. In both groups ORIF of
the distal radius fracture will be similar. The interven-
tion group will be treated with wrist arthroscopy follow-
ing ORIF. A delay of at least five days before performing
arthroscopy is mandatory to enable visualisation due to
the organisation of the hematoma. The operation has to
be performed within three weeks after the initial trauma.
Antibiotic prophylaxis (Cefazoline, 1000 mg i.v.) is
given preoperatively, according to the current standard.
The volar approach according to Henry will be used
[21]. This entails an incision between the radial artery
and the tendon of the flexor carpi radialis. The pronator
quadratus muscle from will be detached from its distal
and lateral side and lifted for optimal exposure to the
fracture site. After the fracture site is revealed, the frac-
ture will be debrided, reduced and fixated with an ap-
propriate volar locking plate. The type and brand of the
plate are at the discretion of the treating surgeon. When
a dorsal approach is deemed necessary the distal radius
will be approached through the third dorsal extensor
tendon compartment, without opening the dorsal cap-
sule. Fluoroscopic images are obtained to evaluate the
quality of articular reduction. Wrist arthroscopy will be
performed when the treating surgeon is satisfied with
the result of the ORIF.
During wrist arthroscopy, the forearm will be positioned
upright and in neutral position, the elbow flexed by 90° and
axial traction of 4–6 kg will be performed. Four portals are
created dorsally by superficial stab incisions and blunt prep-
aration through the joint capsule; one midcarpal radial
(MCR) and ulnar (MCU) portal and one radiocarpal 3-4
and 6-R portal (Fig. 1). Portals may be changed to improve
visualisation. A shaver or mini grasper is used for removal
of fracture haematoma and osteocartilaginous debris. Car-
tilage damage will be graded using the Outerbridge classifi-
cation system [22] (Additional file 3). With the 1-mm hook
probe, assessment of the quality of reduction and ligament-
ous injuries will be performed. Step-off and gaps will be
measured with a calibrated 1-mm probe at the point of
maximum displacement and recorded. The trampoline and
hook test are performed to demonstrate a triangular fibro-
cartilage complex (TFCC) tear. TFCC tears will be classi-
fied according to Palmer [23] (Additional file 4). All
scapholunate ligament injuries will be noted and graded ac-
cording to the Geissler classification [11] (Additional file 5).
Fig. 1 View of wrist arthroscopy portals
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The same classification will be applied for lunotriquetral in-
juries. Wound closure will be performed using standard
techniques. All patients will receive a pressure bandage for
24–48 h.
For both the intervention and the control group, pa-
tients are allowed to start exercising immediately after
the operation. Exercises include pronation and supin-
ation, flexion and extension, and ulnar and radial devi-
ation of the wrist. Patients are instructed to use the
affected extremity as far as pain allows. However, only
non-weight-bearing practice is allowed for the first six
weeks. Rehabilitation with the assistance of a physiother-
apist is recommended at the discretion of the patient
and treating surgeon.
All interventions are performed according to prede-
fined Standard Operating Procedures (SOPs). Individuals
can leave the study at any time for any reason if they
wish to do so without any consequences. The investiga-
tor can decide to withdraw a participant from the study
for urgent medical reasons.
Outcomes
Primary outcome
The primary outcome of this study is wrist pain and dis-
ability expressed as change on the PRWE score after three
months. In addition, the PRWE questionnaire will be
completed after three and six weeks, and six and
12 months of follow-up (Fig. 2). The PRWE is a validated
tool for assessing functional outcome in patients with dis-
tal radius fractures [24, 25]. The PRWE is a 15-item ques-
tionnaire which measures wrist pain and disability in
activities of daily living on a scale of 0–10. Although the
PRWE consists of three subscales (pain, function and cos-
metics), the PRWE results in a single score [26]. The high-
est score, indicating severe impairment, is 100 and the
best score, indicating no impairment, is zero. The Dutch
version has been structurally validated [26]. The PRWE
score will be expressed as a final value at each of the
follow-up moments.
Secondary outcomes
 Wrist function, disability and pain as measured with
the DASH score, at three and six weeks and three,
six and 12 months of follow-up (Fig. 2). The DASH
questionnaire is a 30-item, self-report questionnaire
which measures physical function and symptoms in
patients with any or several musculoskeletal disorders
of the upper limb, including the distal radius [27–29].
The DASH questionnaire tests the degree of difficulty
in performing a variety of physical activities because
of arm, shoulder or hand problems (six items), the
severity of pain, tingling (two items), as well as the
effect of the upper limb problem on social activities,
work and sleep (three items). The highest score is 100,
indicating severe disability and pain; the lowest score
STUDY PERIOD
Enrolment Allocation Post-allocation
TIMEPOINT -t1 0 Baseline
Day 
1
Week 
1
Week 
3
Week 
6
Month 
3
Month 
6
Month 
12
ENROLMENT:
Eligibility screen X
Informed consent X
Allocation X
INTERVENTIONS:
ORIF + wrist 
arthroscopy X
ORIF X
ASSESSMENTS:
Baseline variables X
PRWE X X X X X
DASH X X X X X
VAS X X X X X
Range of motion X X X
Grip strength X X X
Cost-effectiveness X X X
Fig. 2 Follow-up visits
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is zero, indicating no disability and pain. The Dutch
version of the DASH questionnaire has been validated
and has shown to be a reliable and valid instrument
[30]. The DASH score will be expressed as a final
value at each of the follow-up moments.
 Postoperative pain as indicated on a Visual Analogue
Scale (VAS), where zero means no pain and ten the
worst pain possible. Patients will be asked to give an
estimation of their pain and the type and quantity of
pain medication taken postoperatively at one day,
one week, three weeks, six weeks and three months
(Fig. 2). The VAS pain score will be expressed as the
final value at each of the follow-up moments.
 ROM of the wrist measured on both the injured as
well as the uninjured wrist with a handheld
goniometer. Measurements of ROM include ulnar
and radial deviation, pronation and supination, and
flexion and extension of the wrist. ROM is measured
at three weeks, six weeks and three months, and will
be expressed as both a final value and as a
percentage of the uninjured side (Fig. 2).
 Prehensile grip strength as a percentage of the
uninjured wrist. Grip strength will be measured on
both sides with a Baseline dynamometer (White
Plains, NY, USA) with the arm of the patient to the
side and the elbow at 90° flexion. Grip strength will
be calculated as the mean of three measurements
and expressed as a final value and as a percentage of
the uninjured side. Grip strength is measured at
three weeks, six weeks and three months (Fig. 2).
 Complications, such as superficial or deep infection
divided by the criteria of the US Centers for Disease
Control and Prevention [31], tendinitis or rupture of
one of the flexor or extensor tendons, carpal tunnel
syndrome, compartment syndrome, complex
regional pain syndrome (CRPS) type 1 according to
the Veldman [32] and the Budapest criteria [33, 34],
and hardware-related complications will be
recorded.
 Cost-effectiveness and cost-utility of ORIF with and
without an arthroscopic-assisted procedure from a
societal perspective, measured with an economic
evaluation questionnaire at three weeks, six weeks and
three months follow-up. The economic evaluation
questionnaire is based on the EQ-5D and the
Standard Form Health and Labour questionnaire.
The EQ-5D will be used to measure quality-
adjusted life years (QALY). Since this analysis is
from a societal perspective, direct healthcare
costs, direct non-healthcare costs and indirect
costs due to the operative treated distal radius
fracture will be considered (Table 1). A more
detailed description of the economic analysis can
be found in the protocol of the VIPAR trial [35].
The cost-effectiveness is determined at three
weeks, six weeks and three months (Fig. 2).
 In the intervention group the quality of reduction,
associated ligamentous injuries and cartilage damage
will be assessed. Ligamentous injuries are divided in
TFCC injuries, classified according to the Palmer
classification [23], and scapholunate ligament and
lunotriquetral injuries, graded according to the
Geissler classification [11].
Randomisation
All consecutive adult patients who are diagnosed with a
displaced complete articular distal radius fracture (AO/
OTA type C) and scheduled for ORIF will be invited to
participate in this study if they meet the inclusion and
exclusion criteria. Informed consent will be obtained at
the outpatient clinic before the operation. Randomisa-
tion will be performed by means of a computerised ran-
domisation procedure, using Castor®, which is an online
secure randomisation service. Allocation concealment
will be ensured until patients have been randomised,
which takes place after baseline characteristics have
been obtained. The sequence of allocation is concealed
until trial completion. To avoid imbalances between
treatment groups, patients will be randomised in two
strata according to age: 18–65 years and ≥ 65 years
using a mixed block randomisation with blocks of four,
six and eight patients. The order of the block sizes is
unknown to the researchers, who therefore remain
blinded to the allocation of the next individual through-
out the whole study.
Table 1 Costs included in the economic evaluation
Direct healthcare costs
Open reduction and internal fixation
Additional cost of wrist arthroscopy
Follow-up visits medical specialist
Additional visits to healthcare professional
Prescribed medication
Professional home care
Treatment and follow-up of complications
Physical therapy
Direct non-healthcare costs
Travel expenses to and from the hospital
Over the counter medication
Care provided by family or paid help
Assistive devices
Indirect costs
Absenteeism from paid labour (per day)
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Blinding
Since the treatment allocation involves a surgical pro-
cedure and therefore the surgical incision and portal en-
trees will be visible for both physician and patient,
randomisation status will not be blinded.
Sample size calculation
The sample size calculation is based on our primary out-
come, the PRWE score. We choose the PRWE score at
three months as our primary outcome, since we expect
patients to profit most from additional wrist arthroscopy
within three months after the initial trauma. After this
point, the haematoma has dissolved without interven-
tion. The mean PRWE score after a distal radius fracture
after three months of follow-up in adult patients is 28
with a standard deviation of 21.3 [36]. This PRWE score
was measured in a population in which 38% of patients
suffered from a complete articular distal radius fracture
(AO/OTA type C fracture). Although this cohort of pa-
tients is not fully comparable to our cohort of patients,
it is the data which most closely resembles our study
population. We chose an effect size of 18 points on the
PRWE score at three months, since we expect the great-
est difference in PRWE score between both groups at
three months of follow-up. The minimally clinically im-
portant difference is set at 11.5, therefore every differ-
ence > 11.5 is clinically meaningful [37]. Therefore, at α
= 0.05% and a power of 80%, we would require 46 pa-
tients in total and 23 per treatment arm. For safety mea-
sures and with an expected loss to follow-up of 5%, 25
patients in each arm will be included. In a separate study
conducted in the Netherlands by our research group, a
prevalence of AO/OTA type C distal radius fractures of
approximately 25% was found [4]. Therefore, we esti-
mate to include and follow-up all 50 patients in a max-
imum of 1.5 years.
Data analysis
All patients will be analysed according to the intention-
to-treat protocol. General descriptive statistics on patient
characteristic at baseline will be performed including
factors such as gender and age, and presented as per-
centages (categorical variables) or means and standard
deviation (SD) (continuous variables), whichever is ap-
plicable. Normality will be determined by visually
inspecting the plotted data distribution in a histogram.
Differences between the two groups in the primary out-
come, the PRWE score, will be analysed using an ana-
lysis of covariance (ANCOVA), corrected for age. The
same applies for the DASH score at the different follow-
up moments. The secondary outcomes—pain (VAS),
ROM and grip strength—will be analysed using a linear
mixed model. The best covariance structure for each lin-
ear mixed model is determined using the smallest
Akaike information criterion (AIC). The VAS pain score
will be corrected for painkiller use. Differences in com-
plication rates between the two treatment groups will be
analysed using the Chi-square test or Fisher’s exact test
(in case the expected incidence is less than five). Sub-
group analyses will be performed on gender and age.
Multiple imputation will be used in case of > 10% miss-
ing data.
Data management and monitoring
All follow-up moments are part of the regular outpatient
clinic appointments. Data of patients lost to follow-up
will be analysed until the last follow-up appointment.
Data will be stored in two separate files. One dataset will
contain coded patient information, based on an unam-
biguous identification code, and a second set of medical
history linked to these codes. The coordinating investi-
gator safeguards the key to the code. The same applies
for all screened patients. Data are entered in Castor®. All
entered data and changes are saved; a list is maintained
of all individuals who are authorised to make data
changes. A reason is always indicated when changes are
made to the data. All data are adequately backed up and
can be retrieved form the archive. All researchers in-
volved in the study will have access to all data collected.
Data will be stored and kept for 15 years according
standard guidelines.
The Institutional Review Board waived the need for a
data monitoring committee, since both treatment mo-
dalities are part of standard care. An audit is performed
half way during the trial.
Protocol amendments
For any modifications of the study protocol (29
December 2016; version 6) that may impact the study,
approval will be obtained from the Institutional Re-
view Board before implementation. Protocol modifica-
tions are communicated to relevant parties by letter.
Adverse events
All adverse events will be described in the patient file
during consult at any of the follow-up visits or any other
moment if indicated or requested by the patient. This in-
cludes wound infection, complex regional pain syn-
drome, compartment syndrome and any neurovascular
or tendon damage. Complex regional pain syndrome will
be classified according to the ‘Budapest Criteria’ created
and validated by the Budapest consensus group [33, 34].
All serious adverse events (SAE) are reported to the
accredited medical ethics board that approved the proto-
col, within 15 days after the sponsor has first knowledge
of the serious adverse reactions. Arthroscopic-related
complications which require a readmission or reopera-
tion are listed in a periodic overview.
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SAEs that result in death or are life-threatening should
be reported expeditiously. The expedited reporting will
occur not later than seven days after the responsible in-
vestigator has first knowledge of the adverse reaction.
This is for a preliminary report with another eight days
for completion of the report.
All adverse events will be followed until they have
abated or until a stable situation has been reached. De-
pending on the event, follow-up may require additional
tests or medical procedures as indicated, and/or referral
to the general physician or a medical specialist.
Ethics
This study will be conducted according to the principles
of the Declaration of Helsinki (64th WMA General As-
sembly, Fortaleza, Brazil, October 2013) and in accord-
ance with the Medical Research Involving Human
Subjects Act (WMO) and ‘Good Clinical Practice’ guide-
lines. Insurance was set up for compensation for the
study participants who suffer from potential harm.
Dissemination policy
The results of this study will be submitted for publica-
tion in a peer-reviewed journal. The criteria for author-
ship will follow the guidelines established by the
International Committee of Medical Journal Editors.
Discussion
Randomisation status will not be blinded, since the treat-
ment allocation involves a surgical procedure and there-
fore the surgical incision and the portal entrees are
visible for both physician and patient.
Trial status
This trial has finished recruiting patients.
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